Skip to main content
# Title Department Research Member Research Year
581 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom
Department of Radiology Dr. Mohamed Mahmoud Hamdy Abd Ellah Mohamed 2018
582 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2018
583 Serum Immunoglobulin Paraprotein in Patients with Chronic Lymphocytic Leukemia Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2018
584 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2018
585 Telomere dysfunction-related serological markers and oxidative stress markers in rheumatoid arthritis patients: correlation with diseases activity Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2018
586 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Department of Medical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2018
587 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2018
588 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Department of Pediatric Oncology Dr. Shaimaa / Elsayyed Youssef / Ahmed 2018
589 Accuracy of plain antero-posterior radiographic-based methods for measurement of acetabular cup version Department of Radiology Dr. Haisam Ahmed Samy Aly Atta 2018
590 New Look on Ureterocolic Diversion with Adjuvant Radiotherapy; SECI (South Egypt Cancer Institute) Experience Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2018